CAS: 603139-19-1 - Pentanamide,N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]-,(2S)-
Formel:C25H27F4N3O3S
InChl:InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1
InChI Key:InChIKey=FWIVDMJALNEADT-SFTDATJTSA-N
SMILES:N#CC1(NC(=O)C(NC(C2=CC=C(C=C2)C=3C=CC(=CC3)S(=O)(=O)C)C(F)(F)F)CC(F)(C)C)CC1
- Synonyme:
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- N<sup>1</sup>-[(1-Cyanocyclopropyl)-4-fluoro-N<sup>2</sup>-[(1S)-2,2,2-trifluoro-1-[4-methylsulfonyl]-1,1′-biphenyl-4-yl] ethyl]-<span class="text-smallcaps">L</span>-leucinamide
- Odanacatib
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Odanacatib REF: AN-AG0039T3CAS: 603139-19-1 | 98% | Nachfragen | Di 28 Mai 24 | |
Odanacatib REF: TM-T6035CAS: 603139-19-1 | 98.53% | 49,00 €~593,00 € | Di 04 Jun 24 | |
MK-0822 REF: TR-M425015CAS: 603139-19-1 | - - - | 231,00 €~1.253,00 € | Mi 05 Jun 24 | |
MK 0822 REF: 3D-FM65088CAS: 603139-19-1 | Min. 95% | 150,00 €~445,00 € | Fr 07 Jun 24 |
Odanacatib
Ref: AN-AG0039T3
1mg | 70,00 € | |
2mg | 115,00 € | |
5mg | 143,00 € | |
10mg | 152,00 € | |
25mg | 281,00 € | |
50mg | 494,00 € | |
100mg | Nachfragen |
Odanacatib
Ref: TM-T6035
1mg | 49,00 € | |
2mg | 69,00 € | |
5mg | 103,00 € | |
10mg | 165,00 € | |
25mg | 267,00 € | |
50mg | 401,00 € | |
100mg | 593,00 € | |
1ml*10 (DMSO) | 117,00 € |
MK-0822
Ref: TR-M425015
10mg | 231,00 € | |
50mg | 796,00 € | |
100mg | 1.253,00 € |
MK 0822
Ref: 3D-FM65088
10mg | 150,00 € | |
50mg | 445,00 € |